Article 002: Rh-Negative Genetics Separating Fact from Myth

I wanted to clear up a common misconception I’ve seen repeated in Rh-negative spaces. There is a claim that two Rh-negative parents can have an Rh-positive child. While unusual genetic circumstances can complicate RhD typing, this is not what would normally be expected when both biological parents are genuinely RhD-negative.

The RhD blood type is largely determined by the RHD gene, which provides instructions for producing the D antigen found on red blood cells. In the traditional simplified model, Rh-positive is often represented as “D” and Rh-negative as “d.” However, “d” is not actually a separate gene that produces an Rh-negative antigen. In many RhD-negative people, there is simply no functional RHD gene producing the D antigen.

Therefore, if both biological parents are genuinely RhD-negative and neither carries an RHD variant capable of producing the D antigen, an RhD-positive child would not be expected under ordinary inheritance. Situations that appear to contradict this can involve unusual RHD variants, differences in laboratory testing, or other rare genetic circumstances.

This is where weak D and partial D become important.

Some people have variants of the RHD gene that cause the D antigen to be expressed differently. With weak D, the D antigen may be present in smaller amounts on the surface of red blood cells. With partial D, portions of the normal D antigen may be altered or missing. Depending on the particular variant and the testing method being used, a person's RhD status can sometimes produce unexpected or conflicting results.

Modern RHD genotyping can help clarify these situations. Certain common weak D types, particularly weak D types 1, 2, and 3, can generally be managed as RhD-positive, while people with many other weak or partial D variants may need to be managed as RhD-negative because of the potential risk of developing antibodies against the D antigen.

This is also important during pregnancy.

RhD immune globulin, commonly known by the brand name RhoGAM, is used to help prevent RhD alloimmunization in appropriate RhD-negative patients who may be exposed to RhD-positive fetal red blood cells. Decisions about RhD immune globulin should be based on proper blood typing, pregnancy circumstances, and medical guidance rather than assumptions based solely on family blood types.

There has also been discussion of chimerism, a rare biological phenomenon in which one person can possess genetically distinct populations of cells. Chimerism is real and can occasionally create unusual genetic or blood-typing results. However, it is rare and should not be treated as the routine explanation whenever someone's blood-type inheritance appears unexpected.

The same caution should apply to questions of biological parentage. ABO or Rh blood typing by itself should not be treated as definitive proof of parentage or non-parentage. Modern DNA parentage testing is far more definitive, and unusual blood-typing results should be investigated medically rather than used to make assumptions about a family.

We all want people to be informed and protected, especially when discussing pregnancy, transfusions, and blood compatibility. Rh genetics are fascinating, and unusual cases absolutely exist, but rare exceptions shouldn't be presented as though they overturn the basic biology that applies to the overwhelming majority of people.

Sharing speculation as established science can create unnecessary mistrust and confusion, particularly for expectant mothers and families dealing with an already complicated subject. We can explore unusual possibilities while still being clear about the difference between what is biologically possible, what is rare, and what normally occurs.

At the end of the day, blood typing and pregnancy management should be discussed with a doctor, OB-GYN, transfusion-medicine specialist, or other qualified healthcare professional who can interpret the individual's laboratory results and, when appropriate, order more specific testing such as RHD genotyping.

Science becomes more interesting not less when we separate the mysteries worth investigating from the facts we already understand.

References

• MedlinePlus – Rh Incompatibility — Overview of the Rh factor, inheritance, Rh-negative pregnancy, and Rh incompatibility.
• MedlinePlus – Blood Typing — Explains ABO/Rh blood typing and the distinction between Rh-positive and Rh-negative blood.
• National Advisory Committee on Blood and Blood Products – RHD Genotyping in Prenatal Patients — Excellent source for weak D, partial D, RHD genotyping, and why some RhD variants can produce confusing blood-typing results.
• LifeServe Blood Center – Weak D Policy — Clinical blood-center guidance concerning weak D and related transfusion policies.
• ACOG – Prevention of Rh D Alloimmunization — Medical guidance on RhD alloimmunization, Rh immune globulin, pregnancy, and weak D considerations. The guidance is currently listed as reaffirmed in 2026.